Description

Brukinsa is a medication used in the treatment of certain types of cancer, specifically mantle cell lymphoma and chronic lymphocytic leukemia. It works as a Bruton tyrosine kinase inhibitor, which helps to block the growth of cancer cells.

Interpreter Notes

Interpreters may encounter variations in how Brukinsa is referred to, but it is important to use the canonical term in formal contexts. Avoid colloquial terms or regional variations that may arise in patient conversations. Ensure that the context of use is clearly understood, particularly in oncology settings.

Example Sentences

EN: The oncologist prescribed Brukinsa for the patient's treatment plan.

ES: El oncólogo recetó Brukinsa como parte del plan de tratamiento del paciente.

Common Interpreter Mistakes

Confusing Brukinsa with other cancer medications; mispronouncing Brukinsa as a different drug name; using informal terms instead of the canonical term.